228 related articles for article (PubMed ID: 6270349)
1. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
Knopf KW; Kaufman ER; Crumpacker C
J Virol; 1981 Sep; 39(3):746-57. PubMed ID: 6270349
[TBL] [Abstract][Full Text] [Related]
2. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.
Crumpacker CS; Schnipper LE; Kowalsky PN; Sherman DM
J Infect Dis; 1982 Aug; 146(2):167-72. PubMed ID: 6286786
[TBL] [Abstract][Full Text] [Related]
3. Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus.
Crumpacker CS; Kowalsky PN; Oliver SA; Schnipper LE; Field AK
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1556-60. PubMed ID: 6324203
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.
Furman PA; Coen DM; St Clair MH; Schaffer PA
J Virol; 1981 Dec; 40(3):936-41. PubMed ID: 6275127
[TBL] [Abstract][Full Text] [Related]
5. Physical mapping of paar mutations of herpes simplex virus type 1 and type 2 by intertypic marker rescue.
Chartrand P; Stow ND; Timbury MC; Wilkie NM
J Virol; 1979 Aug; 31(2):265-76. PubMed ID: 225553
[TBL] [Abstract][Full Text] [Related]
6. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
[TBL] [Abstract][Full Text] [Related]
7. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
[No Abstract] [Full Text] [Related]
8. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Coen DM; Fleming HE; Leslie LK; Retondo MJ
J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
[No Abstract] [Full Text] [Related]
10. Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.
Schnipper LE; Crumpacker CS
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2270-3. PubMed ID: 6246532
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
Derse D; Bastow KF; Cheng Y
J Biol Chem; 1982 Sep; 257(17):10251-60. PubMed ID: 6286645
[TBL] [Abstract][Full Text] [Related]
13. Resistance of herpes simplex virus to acycloguanosine--genetic and physical analysis.
Crumpacker CS; Chartrand P; Subak-Sharpe JH; Wilkie NM
Virology; 1980 Aug; 105(1):171-84. PubMed ID: 6251603
[No Abstract] [Full Text] [Related]
14. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
Larder BA; Darby G
Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an aphidicolin-resistant mutant of herpes simplex virus type 2 which induces an altered viral DNA polymerase.
Nishiyama Y; Suzuki S; Yamauchi M; Maeno K; Yoshida S
Virology; 1984 May; 135(1):87-96. PubMed ID: 6328755
[TBL] [Abstract][Full Text] [Related]
16. Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1.
Coen DM; Schaffer PA
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2265-9. PubMed ID: 6246531
[TBL] [Abstract][Full Text] [Related]
17. A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin.
Tsurumi T; Maeno K; Nishiyama Y
J Virol; 1987 Feb; 61(2):388-94. PubMed ID: 3027369
[TBL] [Abstract][Full Text] [Related]
18. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
Larsson A; Sundqvist A; Parnerud AM
Mol Pharmacol; 1986 Jun; 29(6):614-21. PubMed ID: 3012321
[TBL] [Abstract][Full Text] [Related]
20. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.
Matthews JT; Carroll RD; Stevens JT; Haffey ML
J Virol; 1989 Nov; 63(11):4913-8. PubMed ID: 2552170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
